1148. Reduction of Blood Culture Contamination Rates by an Altered Sampling Protocol: Single-Center, Prospective, Randomized, Controlled, Open-Label Trial
Jacob Strahilevitz(Hebrew University of Jerusalem), Yonatan Oster(Hadassah Medical Center), Or Svinik(Hebrew University of Jerusalem), Yasmin Sa’id Abed Al-Dayem(Hadassah Medical Center), Alon Lalezari(Hebrew University of Jerusalem), Odaya Tel-Zur(Hadassah Medical Center), Matan J. Cohen, Allon E. Moses(Hadassah Medical Center), Shlomo Sinvani(Hadassah Medical Center)
Cited by 0
Related Papers
Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
|Nature Medicine|2005|1k
Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat
|Clinical Microbiology Reviews|2009|930
<i>qnr</i> Prevalence in Ceftazidime-Resistant <i>Enterobacteriaceae</i> Isolates from the United States
|Antimicrobial Agents and Chemotherapy|2006|576
Plasmid-Mediated Quinolone Resistance
|Microbiology Spectrum|2014|469
Vaginal microbiome transplantation in women with intractable bacterial vaginosis
|Nature Medicine|2019|411